Sonic Healthcare Limited (SHL.AX,SKHCF.PK), an Australian provider of laboratory, pathology, and radiology services, on Tuesday reported a plunge in net profit for the first-half, particularly hurt by Covid-19 related revenue.
Sonic's CEO, Colin Goldschmidt, said: "Whilst our headline numbers for the half-year show significantly lower earnings versus the comparative period, this is the result of having 90% less COVID-related revenue in the current period."
In addition, the company has reaffirmed its annual EBITDA outlook.
For the six-month period, the healthcare firm posted a net income of A$202.311 million or 42.6 cents per share, lesser than A$382.354 million or 80.9 cents per share, recorded for the same period last year.
EBITA stood at A$393.312 million as against previous year's A$609.977 million.
EBITDA declined to A$736.662 million from A$920.191 million in 2022.
Base business revenue stood at A$4.266 billion as against A$3.703 billion in 2022.
Covid-19 related revenue plunged to A$38.691 million from A$378.654 million a year ago.
Total revenue improved to A$4.305 billion from last year's A$4.082 billion.
The company will pay an interim dividend of 43 cents per share, higher than last year's 42 cents per share, to be paid on March 21 to shareholders of record as of March 4.
Looking ahead, for the full year, the company still expects EBITDA more likely towards lower end of guidance of A$1.7 billion to A$1.8 billion.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.